Warp Sciences launches with $215M Series A to apply AI and robotics to drug development
Article timeline
The articles in this story. Times are ET.
- The Robot ReportNewsWarp Sciences emerges from stealth with $215 million to automate drug research chemistry
AIWarp Sciences emerged from stealth with $215 million in funding to build a U.S.-based chemistry contract research organization. The company combines chemists, robotics, and AI to make and test molecules, aiming to generate real-world data for training AI models. Its initial service focuses on lead optimization analog synthesis, and it says it holds no proprietary drug pipeline.
Kevin Weil 🇺🇸XKevin Weil endorses co-founder Sol Reisberg's take on Warp SciencesAIKevin Weil, who owns OpenAI's account, shares a LinkedIn post by his Warp Sciences co-founder Sol Reisberg and calls it an important read from an expert in the space. The post itself contains no details beyond that endorsement and the link.
Fidji SimoXFidji Simo backs Warp Sciences, which pairs AI and robotics for drug discoveryAIFidji Simo says she invested in Warp Sciences, which combines AI and robotics to create a feedback loop for scientific discovery. The quoted post from Kevin Weil introduces Warp as a new company applying AI and robotics to develop medicines faster and reports a $215M Series A led by Lightspeed. The company's co-founders include D.J. Patil and Manohar Paluri.
Andrew CurranXWarp Sciences raises $215M Series A to apply AI and robotics to drug discoveryAIWarp Sciences, founded by former OpenAI CPO Kevin Weil, emerged from stealth with a $215M Series A led by Lightspeed. The company plans to make and test molecules for drug developers using AI and robotics, starting as a preclinical contract research organization in America.
- Kevin Weil 🇺🇸XWarp Sciences launches with $215M Series A to apply AI and robotics to drug development
AIKevin Weil announces Warp Sciences, a new company applying AI and robotics to help develop new medicines faster. Warp raised a $215M Series A led by Lightspeed Venture Partners to bring frontier AI into the lab and build scientific capacity in America.